You’ve been looking for a better way to understand the underlying genomics of human disease. It’s here now.

Dovetail Genomics has proven technology and software that can accelerate your research into human diseases such as oncology, inherited, and undiagnosed diseases.

With the combination of our industry leading proximity ligation techniques and analysis software we can now reveal all classes of large structural variants and 3D features in the human genome.

Seeing and resolving all classes of structural variation is one of the biggest challenges in human disease. We’ve solved it.

There is a growing focus on large structural variants and their role in cancer and other diseases. Current technologies can find structural variants you already know exist, or only identify variants from some classes, such as copy number variations.

FFPE is the de facto archival material for biopsy specimens. For the first time, we can help you see structural variants and 3D features on a genome-wide scale in FFPE.

Think of how many decades of paraffin-embedded biopsy specimens are available in research facilities. How much further could you advance disease research if there was a way to learn more from them? We’re giving you the ability to do just that with Fix-C™ and Selva™ analysis. Reveal previously undetectable structural variants and 3D chromatin features in FFPE samples, and take your research—and our global understanding of the genome—to a whole new level.

Featured Resources


Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

Dr. Helio Costa, PhD 
Stanford University

Tech Sheet

Profile all classes of large variants from FFPE and other sample types

Fix-C™ and Dovetail™ Hi-C with Selva™ Structural Variant Detection identifies large structural variants of all classes, including balanced and complex variants with no upper limit on the size of the variant from all sample types, including FFPE.

Want More? Visit the Resources Archive

We can help you advance research into human disease. Just ask.

Contact us to discover more about this breakthrough technology and how it can help you see further into human disease.

Reach out to get started